Gotowa bibliografia na temat „Hormone immune networks”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Hormone immune networks”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Hormone immune networks"
Meik, Kunz, Ahmed Nazeer, Dandekar Thomas, and Naseem Muhammad. "Hormone Signaling Networks Open Multiple Routes for Immunity and Disease in Plants." Biohelikon 1, no. 2 (2013): 1–3. https://doi.org/10.5281/zenodo.816323.
Pełny tekst źródłaKeith, Scott A. "Steroid hormone regulation of innate immunity in Drosophila melanogaster." PLOS Genetics 19, no. 6 (2023): e1010782. http://dx.doi.org/10.1371/journal.pgen.1010782.
Pełny tekst źródłaDan, Song, and Shi Yichao. "Immune system modifications and feto-maternal immune tolerance." Chinese Medical Journal 127, no. 17 (2014): 3171–80. http://dx.doi.org/10.3760/cma.j.issn.0366-6999.20133072.
Pełny tekst źródłaNaseem, Muhammad, Meik Kunz, and Thomas Dandekar. "Probing the Unknowns in Cytokinin-Mediated Immune Defense in Arabidopsis with Systems Biology Approaches." Bioinformatics and Biology Insights 8 (January 2014): BBI.S13462. http://dx.doi.org/10.4137/bbi.s13462.
Pełny tekst źródłaWang, Hongtao, and Zhiming Xie. "Cullin-Conciliated Regulation of Plant Immune Responses: Implications for Sustainable Crop Protection." Plants 13, no. 21 (2024): 2997. http://dx.doi.org/10.3390/plants13212997.
Pełny tekst źródłaBright, John J., Saravanan Kanakasabai, Wanida Chearwae, and Sharmistha Chakraborty. "PPAR Regulation of Inflammatory Signaling in CNS Diseases." PPAR Research 2008 (2008): 1–12. http://dx.doi.org/10.1155/2008/658520.
Pełny tekst źródłaNagy, Laszlo, Attila Szanto, Istvan Szatmari, and Lajos Széles. "Nuclear Hormone Receptors Enable Macrophages and Dendritic Cells to Sense Their Lipid Environment and Shape Their Immune Response." Physiological Reviews 92, no. 2 (2012): 739–89. http://dx.doi.org/10.1152/physrev.00004.2011.
Pełny tekst źródłaRibarac-Stepic, Nevena, Snezana Djurica, Zorica Zakula, Goran Koricanac, and Dragoslav Milosevic. "Molecular basis of glucocorticoid action." Srpski arhiv za celokupno lekarstvo 133, Suppl. 1 (2005): 61–66. http://dx.doi.org/10.2298/sarh05s1061r.
Pełny tekst źródłaMcKinney, Lawrence P., Rajesh Singh, I. King Jordan, Sooryanarayana Varambally, Eric B. Dammer, and James W. Lillard. "Transcriptome Analysis Identifies Tumor Immune Microenvironment Signaling Networks Supporting Metastatic Castration-Resistant Prostate Cancer." Onco 3, no. 2 (2023): 81–95. http://dx.doi.org/10.3390/onco3020007.
Pełny tekst źródłaZhu, Wenyong, Hao Huang, Zixi Hu, et al. "Comprehensive Transcriptome Analysis Expands lncRNA Functional Profiles in Breast Cancer." International Journal of Molecular Sciences 25, no. 15 (2024): 8456. http://dx.doi.org/10.3390/ijms25158456.
Pełny tekst źródłaRozprawy doktorskie na temat "Hormone immune networks"
Hamy, Anne-Sophie. "Identification of Factors Predicting Sensitivity or Resistance to Neoadjuvant Chemotherapy in Breast Cancer Neoadjuvant treatment : the future of patients with breast cancer Neoadjuvant treatment for intermediate/high-risk HER2-positive and triple-negative breast cancers: no longer an “option” but an ethical obligation Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status BIRC5 (survivin) : a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort The presence of an in situ component on pre-treatment biopsy is not associated with response to neoadjuvant chemotherapy for breast cancer Chemosensitivity, tumor infiltrating lymphocytes (TILs), and survival of postpartum PABC patients treated by neoadjuvant chemotherapy Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma New insight for pharmacogenomics studies from the transcriptional analysis of two large-scale cancer cell line panels Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer Interaction between molecular subtypes, stromal immune infiltration before and after treatment in breast cancer patients treated with neoadjuvant chemotherapy COX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2-negative Breast Cancer Patients Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer." Thesis, Université Paris-Saclay (ComUE), 2019. http://www.theses.fr/2019SACLS129.
Pełny tekst źródłaCzęści książek na temat "Hormone immune networks"
Besedovsky, H. O., and A. del Rey. "Introduction: Immune-Neuroendocrine Network." In Frontiers of Hormone Research. KARGER, 2001. http://dx.doi.org/10.1159/000061055.
Pełny tekst źródłaSullivan, David A. "Hormonal Influence on the Secretory Immune System of the Eye." In The Neuroendocrine-Immune Network. CRC Press, 2018. http://dx.doi.org/10.1201/9781351077194-15.
Pełny tekst źródłaPlas, Eugen, Stephan Madersbacher, and Peter Berger. "Hormonal Changes in Ageing Men." In The Neuroendocrine Immune Network in Ageing. Elsevier, 2004. http://dx.doi.org/10.1016/s1567-7443(04)80012-7.
Pełny tekst źródłaBartke, A., M. Heiman, D. Turyn, F. Dominici, and J. J. Kopchick. "The Role of Growth Hormone Signaling in the Control of Ageing." In The Neuroendocrine Immune Network in Ageing. Elsevier, 2004. http://dx.doi.org/10.1016/s1567-7443(04)80010-3.
Pełny tekst źródłaHugo Del Río-Araiza, Victor, Romel Hernandéz-Bello, and Jorge Morales-Montor. "New Uses for Old Drugs and Their Application in Helminthology." In Parasitic Helminths and Zoonoses - From Basic to Applied Research [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.106176.
Pełny tekst źródłaK. Kanu, Kingsley, and Vincent C. Kanu. "Cultivating Resilience: Exploring Biotic Stressors and Plant Immune Responses." In Physiology. IntechOpen, 2025. https://doi.org/10.5772/intechopen.1006319.
Pełny tekst źródłaRozengurt, E. "Neuropeptide growth factors: signalling pathways and role in cancer." In Cell Proliferation in Cancer. Oxford University PressOxford, 1995. http://dx.doi.org/10.1093/oso/9780198547914.003.0009.
Pełny tekst źródłaRaporty organizacyjne na temat "Hormone immune networks"
Li, Zifeng, Yuling Fan, Yunhong Lei, Xiaoqiang Hou, and Caiyun Chang. A protocol for systematic review and network meta-analysis Efficacy and Safety of Kunxian Capsule in Treating Patients with Lupus Nephritis:A network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.12.0005.
Pełny tekst źródła